Yung Shin Pharmaceutical is an API and finished-dose manufacturer based in Taiwan. It holds 12 active US drug master files across a filed portfolio of 12 molecules. Its filings concentrate with NPRA (MY) and US FDA. Its GMP standing is certified by MFDS (Korea) and EMA. Its most recent recorded inspection, by US FDA, closed on 22 October 2019 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Taiwan, Taiwan | 3002808536 |
| Tachia, Taiwan | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Cabazitaxel | US FDA | 2 |
| Cinacalcet | US FDA | 2 |
| Docetaxel | US FDA | 2 |
| Eletriptan | US FDA | 2 |
| Entecavir | US FDA | 2 |
| Famotidine | US FDA | 2 |
| Meclofenamic Acid | US FDA | 2 |
| Micafungin | US FDA | 2 |
| Omeprazole | US FDA | 2 |
| Paclitaxel | US FDA | 2 |
| Voriconazole | US FDA | 2 |
| Zoledronic Acid | US FDA | 2 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| NPRA (MY) | 16 | None |
| US FDA | 5 | None |
| MFDS (Korea) | None | 2 |
| EMA | None | 1 |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Yung Shin Pharmaceutical comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.